
1. malar j. 2018 dec 17;17(1):471. doi: 10.1186/s12936-018-2620-y.

prevalence molecular markers sulfadoxine-pyrimethamine artemisinin
resistance plasmodium falciparum pakistan.

yaqoob a(1), khattak aa(2), nadeem mf(1), fatima h(3), mbambo g(4), ouattara
a(4), adams m(4), zeeshan n(1), takala-harrison s(5).

author information: 
(1)department biochemistry & biotechnology, university gujrat, gujrat,
pakistan.
(2)department medical laboratory technology, university haripur, haripur,
kpk, pakistan.
(3)department animal sciences, quaid-i-azam university, islamabad, pakistan.
(4)center vaccine development global health, university maryland
school medicine, baltimore, usa.
(5)center vaccine development global health, university maryland
school medicine, baltimore, usa. stakala@som.umaryland.edu.

background: pakistan, artesunate (as) combination with
sulfadoxine-pyrimethamine (sp) recommended treatment uncomplicated
plasmodium falciparum malaria. monitoring molecular markers anti-malarial drug
resistance crucial early detection containment parasite resistance 
to treatment. currently, data available molecular markers of
artemisinin resistance (k13 mutations) p. falciparum isolates pakistan.
in study, prevalence mutations associated sp artemisinin
resistance estimated different regions pakistan.
methods: total 845 blood samples positive malaria parasites by
microscopy rapid diagnostic test collected january 2016 february 
2017 16 different sites pakistan. samples, 300 positive for
p. falciparum pcr. polymorphisms p. falciparum dihydrofolate reductase 
(pfdhfr) dihydropteroate synthase (pfdhps) genes identified by
pyrosequencing polymorphisms propeller domain pfk13 gene were
identified sanger sequencing.
results: prevalence pfdhfr 108n 59r mutations 100% 98.8%, 
respectively, prevalence pfdhfr 50r 51i mutations 8.6%. no
mutation observed pfdhfr position 164. pfdhps, prevalence of
mutations positions 436, 437, 613 9.9%, 45.2%, 0.4%, respectively.
no mutations found pfdhps positions 540 581. prevalence double
pfdhfr mutants (59r + 108n) ranged 93.8% 100%, prevalence of
parasites pfdhfr 59r + 108n mutations addition pfdhps 437g
mutation ranged 9.5% 83.3% across different regions pakistan. nine
non-synonymous four synonymous mutations observed pfk13 propeller
domain, none correspond mutations validated contribute to
artemisinin resistance.
conclusion: absence highly resistant pfdhfr/pfdhps quintuple mutant
parasites lack pfk13 mutations associated artemisinin resistance 
is consistent as + sp effective pakistan.

doi: 10.1186/s12936-018-2620-y 
pmcid: pmc6296135
pmid: 30558587  [indexed medline]

